SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-13-000655
Filing Date
2013-03-12
Accepted
2013-03-12 07:03:40
Documents
8
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1312709.htm 20-F 3624370
2 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 16490
3 EXHIBIT 12.2 exhibit_12-2.htm EX-11.2 17833
4 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5393
5 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5325
6 EXHIBIT 15.5 exhibit_15-5.htm EX-15.5 6467
7 pwc.jpg GRAPHIC 3229
8 chart.jpg GRAPHIC 43731
  Complete submission text file 0001178913-13-000655.txt   3741907
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35223 | Film No.: 13682531
SIC: 2834 Pharmaceutical Preparations